by | Jul 6, 2026 | Mgboji, Glory, Wilson, John
— Published Date: 7/7/2026
Value Proposition: Eye occluder glasses that provide a steady, hands-free opportunity to efficiently measure visual acuity.
Technology Description
Researchers at Washington University in St. Louis have developed a pair of eye occluder glasses with a pinhole that can b…
by | Jul 6, 2026 | Chadda, Ankita, Galburt, Eric, Lohman, Timothy, Nguyen, Binh
— Published date: 7/7/2026
Value Proposition: Novel covalent dimerization of UvrD helicase that enhances DNA unwinding processivity and isothermal polymerase chain reaction.
Technology Description
Researchers at Washington University in St. Louis have developed a modified Superfamily 1A helicase …
by | May 22, 2026 | Dantas, Gautam, Li, Ruihao, Wencewicz, Timothy, Xue, Yao-Peng
— Published date: 5/23/2026
Value Proposition: Covalent mechanism-based inhibitors of tetracycline destructases for treating infectious diseases.
Technology Description
Researchers at Washington University in St. Louis have developed a group of C9-modified anhydrotetracyclines that inhibit tetra…
by | May 22, 2026 | Baldelomar, Edwin, Bennett, Kevin
— Published date: 5/23/2026
Value Proposition: Method that uses non-contrast MRI to measure nephron number for individualized assessment of kidney functional capacity.
Technology Description
Researchers at Washington University in St. Louis have developed a method of using non-contrast MRI to d…
by | Apr 20, 2026 | Mishra, Richa, Silva-Fisher, Jessica
— Published date: 4/18/2026
Value Proposition: Combination cancer therapy that utilizes long non-coding RNA and CDK4/6 inhibitors to treat breast cancer.
Technology Description
Researchers at Washington University in St. Louis have developed a cancer combination therapy using CDK4/6 inhibitors an…